April 28, 2006 -- QuatRx was supposed to make its IPO debut this week, but the offering is now listed on the schedule as being “day-to-day,” an ominous reminder of 2005, when about half of the prospective biotech IPOs did not complete the final step. We take an investor’s look at QuatRx, its history, its drugs, its finances...
